(Q37121344)

18 August 2017

1 reference

title

Medication-related complications in the trauma patient (English)

1 reference

18 August 2017

1 reference

Stephanie Mallow Corbett

series ordinal

1

1 reference

18 August 2017

Jill A Rebuck

series ordinal

2

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Journal of Intensive Care Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

23

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

91-108

1 reference

Adverse drug events in trauma patients

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Midazolam and 2% propofol in long-term sedation of traumatized critically ill patients: efficacy and safety comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol as Used for Sedation in the ICU

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol for sedation in the intensive care unit: essentials for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Sedation for the critically ill neurologic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Lactic acidemia and bradyarrhythmia in a child sedated with propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Clinical management of cardiogenic shock associated with prolonged propofol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Long-term propofol infusion and cardiac failure in adult head-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol toxicity in critically ill pediatric patients: show us the proof.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol infusion syndrome in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Rare but dangerous adverse effects of propofol and thiopental in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Lactic acidosis associated with propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol-infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Metabolic acidosis associated with propofol in the absence of other causative factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Lactic acidosis during propofol-remifentanil anesthesia in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The syndrome of irreversible acidosis after prolonged propofol infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A case of suspected non-neurosurgical adult fatal propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Survival of propofol infusion syndrome in a head-injured patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Impaired fatty acid oxidation in propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Lactic acidosis: an early marker of propofol infusion syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Death after re-exposure to propofol in a 3-year-old child: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Short-term propofol infusions in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Lactic acidosis following short-term propofol infusion may be an early warning of propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol infusion syndrome: an unusual cause of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A case of propofol toxicity: further evidence for a causal mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Fatal propofol infusion syndrome in association with ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol infusion syndrome during anaesthesia for scoliosis surgery in an adolescent with neonatal progeroid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Can we blame propofol for pancreatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Acute pancreatitis after single-dose exposure to propofol: a case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Sedation in the intensive care unit: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Intramuscular olanzapine in the management of acute agitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Quetiapine poisoning: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Aminoglycoside dosing considerations in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Gentamicin dosing in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Pharmacodynamics and dosing of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Symposium on antimicrobial agents--Part XII. Vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

21 January 2018

Vancomycin: a history

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Outcome assessment of minimizing vancomycin monitoring and dosing adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Desensitization protocols for vancomycin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Piperacillin/tazobactam: a critical review of the evolving clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Reversible bone marrow depression by high-dose piperacillin/tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Carbapenems and monobactams: imipenem, meropenem, and aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Quinolones: cardioprotective or cardiotoxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Fluoroquinolone-associated dysglycemias: a tale of two toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Outpatient gatifloxacin therapy and dysglycemia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Linezolid contributed to Clostridium difficile colitis with fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Clinical experience with recently approved antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Clindamycin, metronidazole, and chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Noncardiac surgery: postoperative arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Supraventricular tachycardia: implications for the intensivist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

QT Prolongation and Fatal Arrhythmias: A Review of Clinical Implications and Effects of Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Current management of symptomatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Reversible amiodarone-induced lung disease: HRCT findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Use of low molecular weight heparin in preventing thromboembolism in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Silent deep vein thrombosis in immobilized multiple trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Venous thromboembolism in patients with major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Prevention of venous thromboembolism after injury: an evidence-based report--part I: analysis of risk factors and evaluation of the role of vena caval filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Spontaneous spinal hematomas and low-molecular-weight heparin. Report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Dosing and monitoring of low-molecular-weight heparins in special populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The management of anticoagulation before and after procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Physiology of vasopressin relevant to management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

High-dose vasopressin is not superior to norepinephrine in septic shock*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Effects of norepinephrine alone and norepinephrine plus dopamine on human intestinal mucosal perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Management of vasodilatory shock: defining the role of arginine vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Hemodynamic support in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Effect of norepinephrine on the outcome of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Therapeutic implications of immune-endocrine interactions in the critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

The adrenal response after severe trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Stress-hyperglycemia, insulin and immunomodulation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Drug-induced pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Fracture risk associated with systemic and topical corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Allergic and pseudoallergic reactions induced by glucocorticoids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Corticosteroid-induced hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Acute corticosteroid myopathy in intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Steroid-induced myopathy in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Mortality amongst multiple trauma patients admitted to an intensive therapy unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Etomidate infusion and adrenocortical function. A study in elective surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Adrenocortical dysfunction following etomidate induction in emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066607312966

21 January 2018

Identifiers

DOI

10.1177/0885066607312966

1 reference

18 August 2017

1 reference